{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"27.01","upperLimit":"44.19","value":"33.7"},{"comment":"Due to insufficient number of participants with events, median and the upper limit of the survival curve hasn't reached 50%, there is no estimate for the median and the upper confidence limit on the median.","groupId":"OG001","lowerLimit":"38.70","upperLimit":"NA","value":"NA"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"143"},{"groupId":"OG001","value":"146"}],"units":"Participants"}],"description":"Overall survival was defined as the time from randomization to death from any cause.","dispersionType":"95% Confidence Interval","groups":[{"description":"Gemcitabine 1000 mg/m² IV are given on Days 1 \\& 8, and cisplatin 80 mg/m² IV are given on Day 1 of each cycle，placebo will be administered at the dose of 240 mg Q3W before that. Chemotherapy is given Q3W for up to 6 cycles and placebo for up to 2 years","id":"OG000","title":"Placebo Combine With Chemotherapy"},{"description":"Gemcitabine 1000 mg/m² IV are given on Days 1 \\& 8, and cisplatin 80 mg/m² IV are given on Day 1 of each cycle，JS001 will be administered at the dose of 240 mg Q3W before that. Chemotherapy is given Q3W for up to 6 cycles and JS001 for up to2years","id":"OG001","title":"TORIPALIMAB INJECTION(JS001 )Combine With Chemotherapy"}],"paramType":"MEDIAN","populationDescription":"NE below means \"not estimable\".","reportingStatus":"POSTED","timeFrame":"The time frame of OS collected is upto about 48months.","title":"OS","type":"SECONDARY","unitOfMeasure":"months"}